D'Andrea Carrie 4/A
4/A · Acasti Pharma Inc. · Filed May 10, 2024
Insider Transaction Report
Form 4/AAmended
D'Andrea Carrie
VP Clinical Operations
Transactions
- Award
Stock Options (Right to Buy)
2024-05-06+19,740→ 19,740 totalExercise: $2.96Exp: 2034-05-06→ Class A Common Shares (19,740 underlying)
Footnotes (2)
- [F1]This amendment to Form 4 is being filed to amend the signature block in the original Form 4, filed on May 8, 2024, to reflect the correct signatory.
- [F2]Stock options granted on 05/06/2024 under the Acasti Pharma Stock Option Plan, which vest quarterly in equal installments over a 36-month period.